Synovial sarcoma
Showing 1 - 25 of 1,545
Synovial Sarcoma Trial in Philadelphia
Recruiting
- Synovial Sarcoma
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 21, 2023
Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)
Not yet recruiting
- Synovial Sarcoma
- Fludarabine phosphate
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 9, 2023
Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)
Recruiting
- Ewing Sarcoma
- +2 more
- Peptide vaccine IPX
-
Frankfurt am Main, Germany
- +2 more
Oct 18, 2023
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Tumors Trial in Worldwide (Letetresgene autoleucel)
Active, not recruiting
- Neoplasms
- Letetresgene autoleucel
-
Pittsburgh, Pennsylvania
- +5 more
Aug 7, 2023
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma Trial in Worldwide (AL3818, Dacarbazine, AL3818 or )
Active, not recruiting
- Alveolar Soft Part Sarcoma
- +3 more
- AL3818
- +2 more
-
Phoenix, Arizona
- +22 more
Nov 1, 2022
Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))
Recruiting
- Synovial Sarcoma
- Myxoid Liposarcoma
- afamitresgene autoleucel (previously ADP-A2M4)
-
Duarte, California
- +26 more
Dec 7, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)
Recruiting
- Soft Tissue Sarcoma Adult
- +6 more
-
Bordeaux, FranceInstitut Bergonie
Feb 1, 2022
Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene
Not yet recruiting
- Synovial Sarcoma
- +3 more
- Afamitresgene autoleucel
-
Palo Alto, California
- +3 more
Dec 6, 2022
Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)
Temporarily not available
- Epithelioid Sarcoma (Ex-US Only)
- +19 more
- (no location specified)
Oct 17, 2022
Synovial Sarcoma Trial in New York (ipilimumab)
Terminated
- Synovial Sarcoma
- ipilimumab
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 23, 2021
Synovial Sarcoma, Single or Multiple Lung Metastases Trial in United States (Whole Lung IMRT)
Completed
- Synovial Sarcoma
- Single or Multiple Lung Metastases
- Whole Lung IMRT
-
Basking Ridge, New Jersey
- +4 more
Jun 7, 2021
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Relapsed or Refractory Synovial Sarcoma Trial in Osaka, Tokyo (OTSA101-DTPA-111In, OTSA101-DTPA-90Y)
Recruiting
- Relapsed or Refractory Synovial Sarcoma
-
Osaka, Japan
- +2 more
Apr 12, 2021